Through its inhibitory signaling, BTLA not only dampens effector T cell function but also reinforces immunosuppressive networks dominated by Tregs, contributing to tumor immune evasion and resistance to immunotherapy [75]. This evidence concerns the gene BTLA and neoplasm.